Lv1
24 积分 2025-09-23 加入
Observation on the short-term efficacy of telitacicept in the treatment of primary IgA nephropathy
29天前
已完结
CAR T-cell therapy in SLE: A systematic review
5个月前
已完结
CAR T-cell therapy in autoimmune diseases: Opportunities and challenges, with implications for RA
5个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
5个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
5个月前
已完结
Barriers to CAR T-cell therapy in rheumatology
5个月前
已完结
Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study
7个月前
已完结
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
7个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
7个月前
已完结
皖公网安备34019202002308
